Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
"The resoundingly positive data from EXPLORER bring us a significant step closer to improving the lives of people with serious cardiovascular conditions, starting with HCM, a debilitating disease estimated to affect one in every 500 people," said Tassos Gianakakos, Chief Executive Officer of MyoKardia. "The activity and tolerability profile observed for mavacamten in this pivotal study underscores the profound impact and potential for therapeutics that target the underlying biology of disease. We look forward to the submission of MyoKardia's first New Drug Application and, importantly, to serving the many patients that stand to benefit from mavacamten."
nice trick...lol
MYOK is total Junk they pumped it up to $45 so the crooked execs could dump it..... HEY.. that sounds like a pump and dump, come to think of it.
Sanofi stepping up
http://ih.advfn.com/p.php?pid=nmona&article=75460898
Now owns over 4 m shares
Kiwi
Bernstein
Altho small numbers in trial results were statistically significant ...primary end pt ..p=0.002
Clinically and statistically significant improvements were also observed in peak VO2 ...p =0.004
So very low possibility that these benefits were simply by chance .
Sanofi is a partner and they would have certainly done their DD before investing . They certainly now have a lot of cash ...the capital raise went out at a premium !
They will almost certainly apply for fast track and possibly break thru staus which will enable rolling submissions of data and cut probably 18 mths off development time to FDA approval.
The form 4's you referenced were pre planned sales .
Kiwi
$1.2 BILLION for a one trick pony junk which still has to conduct a large phase 3 trial which will take years to finish is for me definitely brutally overpriced . And a 10 patients trial is a big joke almost every Drug works in such small numbers of patients its even worthless to talk about these results . Oh and look at the dumping by Insiders and Institutions in last days , FMR as an example dumped 1.6 million shares yesterday they know this heavily pumped trash has an astronomical valuation .
Berstein ..actually you are way off on MYOK.
Whats fascinating is the speed of response ....." In eight of the 10 subjects the post exercise peak LVOT gradient was reduced below the diagnostic threshold for oHCM ".....after only 12 wks of treatment .
Clinically meaningful improvement was seen as early as in 2 weeks of treatment in some.
This is huge IMHO . May not be as good in P 3 with larger numbers but nevertheless its a great start.
They will almost certainly apply for Fast track , possibly Break Thru FDA status. Trials will be short ..say 6 mths with rolling data submitted and starting EOY.
This is not a company to short
JMO
Kiwi
$1.2 BILLION Bubble /most advanced drug is in phase 2 for which they released ridiculous results from 10patients . Phase 3 will take minimum 6-8 years untill any results are available means you can expect more dilutions in the coming years . This is one of the most overpriced scam in the sector .
https://www.advfn.com/news_Prospectus-Filed-Pursuant-to-Rule-424b5-424b5_75403088.html
============
going down
down
down
till 17
Offering Coming :(
Amazing, such a legit corp. with awesome management and a return of 140% for me and only 5 posts. Shows how IHUB is, all about the flip and BS
FANTASTIC short opp created today on ridiculous phase 2 results from 10 patients . This one trick pony junk is valued close to $1 billion and they are minimum 7 years away from approval if ever . They burning around $15 million a qurter so there will be many dilutions .
Partner Fund Management, L.P. has filed a new 13G, reporting 5.2% ownership in $MYOK - https://fintel.io/so/us/myok
Here’s What To Look For Ahead Of The Myokardia Phase II http://marketexclusive.com/heres-what-to-look-for-ahead-of-the-myokardia-inc-nasdaqmyok-phase-ii/9028/?icd1
Followers
|
6
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
17
|
Created
|
06/16/16
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |